TruGraf & TRAC Combine to Deliver the Most Comprehensive, Noninvasive Kidney Rejection DiagnosticsXiomara Ortiz2020-05-30T09:52:12-05:00May 2020|Read More
The American Journal of Transplantation Honors Transplant Genomics Advisor with 2020 Outstanding Article AwardXiomara Ortiz2020-05-28T14:05:48-05:00May 2020|Read More
Labs@Home™ Facilitates Outpatient Management of Kidney Transplants During COVID-19 – TruGraf® and Labs@Home reduce risks of surveillance biopsies during COVID-19Nicole Moore2020-05-21T10:25:14-05:00May 2020|Read More
Dr. Peter Meintjes Joins Transplant Genomics as Chief Commercial OfficerXiomara Ortiz2020-04-28T16:37:07-05:00April 2020|Read More
Eurofins – Transplant Genomics Announces TRULO Registry Study to Evaluate Long-Term Clinical Outcomes in Patients Monitored with TruGraf® TestingTruGraf2020-04-15T14:18:25-05:00April 2020|Read More
Remote Testing Options to Support Care for Kidney Transplant RecipientsTruGraf2020-04-15T13:58:22-05:00March 2020|Read More
Transplant Genomics, Inc. Appoints Dr. John Holman as VP Medical AffairsTruGraf2020-02-25T18:07:26-06:00January 2020|Read More
Transplant Genomics, Inc. Founders Awarded US Patent Covering Detection of “Silent” Sub-Clinical Rejection in Stable Kidney Transplant RecipientsTruGraf2020-02-25T18:07:26-06:00October 2019|Read More
Transplant Genomics, Inc. Confirms TruGraf® Will Receive Medicare Coverage Effective November 25, 2019TruGraf2020-02-25T18:07:26-06:00October 2019|Read More
Medicare Issues Draft Local Coverage Determination (LCD) for Transplant Genomics’ TruGraf® Blood Test as Alternative to Surveillance BiopsiesTruGraf2020-02-25T18:07:27-06:00March 2019|Read More
